Related Experiment Video
Updated: Apr 16, 2026
04:32
A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
8.3K
Heparin-induced thrombocytopenia
Łukasz J Krzych1, Elżbieta Nowacka, Piotr Knapik
1Department of Cardiac Anaesthesia and Intensive Therapy, Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, Poland. l.krzych@wp.pl.
Anaesthesiology Intensive Therapy
|March 10, 2015
Summary
Heparin-induced thrombocytopenia (HIT) is a serious immune reaction to heparin, causing thrombosis. Early detection via platelet monitoring and specific tests, followed by direct thrombin or Xa factor inhibitors, is crucial for management.
Area of Science:
- Clinical Medicine
- Hematology
- Immunology
Background:
- Heparin-induced thrombocytopenia (HIT) is an immune-mediated syndrome linked to arterial and venous thrombosis.
- HIT risk is highest between days 4-14 of heparin therapy, necessitating regular platelet count monitoring in intensive care units.
Purpose of the Study:
- To outline diagnostic strategies and treatment recommendations for heparin-induced thrombocytopenia.
- To highlight the limitations in advanced diagnostic test availability in certain regions.
Main Methods:
- Clinical assessment using scoring systems (4Ts or HEP) and IgG antibody immunoassays for HIT risk stratification.
- Withdrawal of heparin and initiation of alternative anticoagulation if HIT is suspected.
- Treatment with direct thrombin or Xa factor inhibitors as the preferred approach.
Main Results:
- New-generation anticoagulants are the treatment of choice, while vitamin K antagonists should be avoided initially due to potential aggravation of thrombosis.
- Antithrombotic therapy duration varies based on HIT presentation (isolated thrombocytopenia vs. thrombotic complications).
Conclusions:
- Prompt diagnosis and appropriate anticoagulation are vital for managing HIT and preventing thrombotic events.
- Adherence to monitoring and treatment guidelines can improve patient outcomes in HIT.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:29Venous Thrombosis III: Interprofessional Care
473
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
473
01:24Disorders of Hemostasis
2.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
01:30Venous Thrombosis I: Introduction
742
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
742
01:05Introduction to Hemostasis
18.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
18.9K
01:22Formation of the Platelet Plug
11.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
11.0K